Effect of pravastatin on cisplatin-induced nephrotoxicity in rats

Human and Experimental Toxicology

Volumn 30, Issue 7, 2011, Pages 603-615

  Fujieda, Mikiya ^a   Morita, Taku ^a   Naruse, Keishi ^b   Hayashi, Yoshihiro ^a   Ishihara, Masayuki ^a   Yokoyama, Tadafumi ^c   Toma, Tomoko ^c   Ohta, Kazuhize ^c,d   Wakiguchi, Hiroshi ^a  

^a KOCHI UNIVERSITY   (Japan)

^b The University of Tokushima   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

Author keywords

cisplatin; oxidative stress; p53; pravastatin; triglyceride

Indexed keywords

CISPLATIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID; MALONALDEHYDE; MESSENGER RNA; PRAVASTATIN; PROTEIN P53; PUMA PROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET THERAPY; DRUG INDUCED DISEASE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE FUNCTION; LIPID BLOOD LEVEL; MALE; MICROSCOPY; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CISPLATIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MALONDIALDEHYDE; PRAVASTATIN; RATS; RATS, WISTAR; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

RATTUS; RATTUS NORVEGICUS;

EID: 79959762506     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110376551     Document Type: Article

References (38)

1. Lebwohl D., Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998 ; 34: 1522-1534. (Pubitemid 28446332)
2. Blachley ID, Hill JB Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 1981 ; 95: 628-632. (Pubitemid 12231806)
3. Masuda H., Tanaka T., and Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994 ; 203: 1175-1180. (Pubitemid 24304953)
4. Kruidering M., Van de Water B., de Heer E., Mulder GJ, and Nagelkerke JF Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 1997 ; 280: 638-649. (Pubitemid 27171323)
5. Matsushima H., Yonemura K., Ohishi K., and Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 1998 ; 131: 518-526. (Pubitemid 28278570)
6. Zhang JG, Lindup WE Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem Pharmacol 1993 ; 45: 2215-2222. (Pubitemid 23171082)
7. Abdel-Gayoum AA, El-Jjenjan KB, and Ghwarsha KA Hyperlipidemia in cisplatin-induced nephritic rats. Hum Exp Toxicol 1999 ; 18: 454-459.
8. Portilla D., Li S., Nagothu KK, Megyesi J., Kaissling B., Schnackenberg L., et al. Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int 2006 ; 69: 2194-2204. (Pubitemid 43882106)
9. Tsuruya K., Yotsueda H., Ihada H., Taniguchi M., Masutani K., Hayashide H., et al. Involvement of p53-transactivated Puma in cisplatin-induced tubular cell death. Life Sci 2008 ; 85: 550-556.
10. Weitz-Schmidt G., Welzenback K., Brinkmann V., Kamata T., Kallen J., Bruns C., et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nature Med 2001 ; 7: 687-692. (Pubitemid 32588024)
11. Schonbeck U., Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 2004 ; 109: 1118-1126.
12. Sharyo S., Yokota-Ikeda N., Mori M., Kumagai K., Uchida K., Ito K., et al. Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int 2008 ; 74: 577-584.
13. Takemoto M., Node K., Nakagami H., Liao Y., Grimm M., Takemoto Y., et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001 ; 108: 1429-1437. (Pubitemid 33091980)
14. Wassmann S., Laufs U., Muller K., Konkol C., Ahlbory K., Baumer AT, et al. Cellular antioxidant effects of atorvastatin in vivo and in vitro. Arterioscler Thromb Vasc Biol 2002 ; 22: 300-305. (Pubitemid 34127043)
15. Maack C., Kartes T., Kilter H., Schafers HJ, Nickenig G., Bohm M., et al. Oxygen free radical release in human failing myocardium is associated with increased activity of Racl-GTPase and represents a target for statin treatment. Circulation 2003 ; 108: 1567-1574. (Pubitemid 37187782)
16. Fujieda M., Naruse K., Hamauzu T., Miyazaki E., Hayashi Y., Enomoto R., et al. Effect of selenium on cisplatin-induced nephrotoxicity in rats. Nephron Exp Nephrol 2006 ; 104: e112 - e122.
17. Coelho-Filho OR, De Luca IMS, Tanus-Santos JE, Cittadino M., Sampaio RC, Coelho OR, et al. Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats. Int J Cardiol 2001 ; 79: 215-221. (Pubitemid 32673683)
18. Wei Q., Dong G., Yang T., Megyesi J., Price PM, and Dong Z. Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 2007 ; 293: F1282 - F1291.
19. Wasowicz W., Neve J., and Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993 ; 39: 2522-2528.
20. Aykac G., Uysal M., Yalcin AS, Kocak-Toker N., Sivas A., and Oz H. The effect of chronic ethanol ingestion on heptic lipid peroxide, glutathione transferase in rats. Toxicology 1985 ; 36: 71-76. (Pubitemid 15041735)
21. Lowry OH, Rosebrough NI, Farr AL, and Randall RJ Protein measurement with Folin phenol reagent. J Biol Chem 1952 ; 193: 265-275.
22. Paglia DE, Valentine WN Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967 ; 70: 158-169.
23. L'Abbe MR, Trick KD Changes in pancreatic glutathione peroxidase and superoxide dismutase activities in the prediabetic diabetes-prone BB rat. Proc Soc Exp Biol Med 1994 ; 207: 206-212. (Pubitemid 24323769)
24. Chen MM, Lam A., Abraham JA, Schreiner GF, and Joly AM CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000 ; 32: 1805-1819.
25. Pabla N., Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008 ; 73: 994-1007. (Pubitemid 351543900)
26. Pabla N., Huang S., Mi QS, Daniel R., and Dong Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 2008 ; 283: 6572-6583.
27. Paajarvi G., Roudier E., Crisby M., Hogberg J., and Stenius U. HMG-CoA reductase inhibitors, statin, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage. FASEB J 2005 ; 19: 476-478. (Pubitemid 40316555)
28. Huang Q., Dunn R., Jayadev S., DiSorbo O., Pack FD, Farr SB, et al. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 2001 ; 63: 196-207. (Pubitemid 32982793)
29. Iseri S., Ercan F., Gedik N., Yuksel M., and Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 2007 ; 230: 256-264. (Pubitemid 46109145)
30. Grosser N., Erdmann K., Hemmerle A., Bemdt G., Hinkelmann U., Smith G., et al. Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun 2004 ; 325: 871-876. (Pubitemid 39487953)
31. Lee TS, Chang CC, Zhu Y., and Shyy JY Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004 ; 110: 1296-1302. (Pubitemid 39202348)
32. Kido M., Ando K., Oba S., and Fujita T. Renoprotective effect of pravastatin in salt-loaded Dahl salt-sensitive rats. Hypertens Res 2005 ; 28: 1009-1015.
33. Bezerra DG, Mandarin-de-Lacerda CA Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodeling and glomeruli loss in spontaneously hypertensive rats. Clin Sci 2005 ; 108: 349-355. (Pubitemid 40516998)
34. Ohara Y., Peterson TE, and Harrison DG Hypercholesterolemia increased endothelial superoxide anion production. J Clin Invest 1993 ; 91: 2546-2551. (Pubitemid 23182507)
35. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002 ; 106: 1211-1218. (Pubitemid 34988638)
36. Finlay GA, Malhowski AJ, Liu Y., Fanburg BL, Kwiatkowski DJ, and Toksoz D. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. Cancer Res 2007 ; 67: 9878-9886. (Pubitemid 47621236)
37. Lieberthal W., Fuhro R., Andry CC, Rennke H., Abernathy VE, Koh JS, et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001 ; 281: F693 - F706.
38. Lui SL, Chan KW, Tsang R., Yung S., Lai KN, and Chan TM Effect of rapamycin on renal ischemic-reperfusion injury in mice. Transplantation Int 2006 ; 19: 834-839. (Pubitemid 44358851)